CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
5 research outputs found
Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCELâ„¢), a multi-targeted kinase inhibitor
Author
A Lipton
A Serrels
+47Â more
Amy Camuso
Anne Blackwood-Chirchir
BJ Druker
DB Mendel
DK Luttrell
E Fox
EA Gehan
Feng (Roger) Luo
FR Luo
FR Luo
Francis Y. Lee
H Wu
Holly Palme
J Baselga
J Baselga
J Baselga
J Cortes
J Haier
JR Wiener
JS Biscardi
JW Park
Kelly McGlinchey
Krista Fager
M Talpaz
M Wolf
MC Frame
Mei-Li Wen
MP Lutz
MT Brown
MV Barone
NN Mazurenko
NP Shah
R Roskoski Jr
RB Irby
RD Mass
Richard Smykla
RJ Budde
Robert Wild
S Nam
S Roche
SB Kanner
SB Kanner
Susan Galbraith
TC Windham
W Mao
Yu Chen Barrett
Zheng Yang
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Full text link
Crossref
Quiescent Chronic Myelogenous Leukemia (CML) Cells Are Resistant to BCR-ABL Inhibitors but Preferentially Sensitive to BMS-214662, a Farnesyltransferase Inhibitor (FTI) with Unique Quiescent-Cell Selective Cytotoxicity.
Author
Amy Camuso
Christine Flefleh
+12Â more
David Kan
Francis Y. Lee
Ivan Inigo
Kelly McGlinchey
Krista Fager
Mei-Li Wen
Richard Smykla
Robert Kramer
Roberto Weinmann
Roger Luo
Stephen Castenada
Veeraswamy Manne
Publication venue
'American Society of Hematology'
Publication date
Field of study
No full text
Crossref
Dasatinib (BMS-354825) Overcomes Multiple Mechanisms of Imatinib Resistance in Chronic Myeloid Leukemia (CML).
Author
Amy Camuso
Christine Flefleh
+13Â more
David Kan
Francis Y. Lee
Ivan Inigo
Kelly McGlinchey
Krista Fager
Louis Lombardo
Mei-Li Wen
Rajeev Bhide
Richard Smykla
Robert Borzilleri
Robert Wild
Roger Luo
Stephen Castenada
Publication venue
'American Society of Hematology'
Publication date
Field of study
No full text
Crossref
Pharmacokinetics- and Pharmacodynamics-Guided Optimization of the Dose and Treatment Schedule for the Dual SRC/ABL Inhibitor BMS-354825.
Author
Amy Camuso
Christine Flefleh
+14Â more
David Kan
Feng Roger Luo
Francis Y. Lee
Ivan Inigo
Kelly McGlinchey
Krista Fager
Louis Lombardo
Mei-Li Wen
Richard Smykla
Robert Borzilleri
Robert Kramer
Robert Wild
Stephen Castenada
Zheng Yang
Publication venue
'American Society of Hematology'
Publication date
Field of study
No full text
Crossref